Evidence map›Paper›PMID 40444147›Full record

ArticleFrontiers in global women's health2025

Genna M Losinski, Mickeal N Key, Eric D Vidoni, Jonathan Clutton, Jill K Morris, Jeffrey M Burns, Amber Watts

Abstract read
In one paragraph

Article in Frontiers in global women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. International journal of molecular sciences · 2025
    Article
  4. Review
4 · The record

Corrections and comments

  • Update of
    2024
5 · Who and what money

Authors and funding

7 authors.

Genna M LosinskiDepartment of Psychology, University of Kansas, Lawrence, KS, United States.
Mickeal N KeyDepartment of Neurology, University of Kansas Alzheimer's Disease Center, University of Kansas Medical Center, Fairway, KS, United States.
Eric D VidoniDepartment of Neurology, University of Kansas Alzheimer's Disease Center, University of Kansas Medical Center, Fairway, KS, United States.
Jonathan CluttonDepartment of Neurology, University of Kansas Alzheimer's Disease Center, University of Kansas Medical Center, Fairway, KS, United States.
Jill K MorrisDepartment of Neurology, University of Kansas Alzheimer's Disease Center, University of Kansas Medical Center, Fairway, KS, United States.
Jeffrey M BurnsDepartment of Neurology, University of Kansas Alzheimer's Disease Center, University of Kansas Medical Center, Fairway, KS, United States.
Amber WattsDepartment of Psychology, University of Kansas, Lawrence, KS, United States.

Funding

University of Kansas Alzheimer's Disease Research Center (KU ADRC)P30AG072973 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Mohammad Haeri · 2021 to 2026
$25.3M
University of Kansas Alzheimer's Disease Core CentersP30AG035982 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI SWERDLOW, RUSSELL H. · 2011 to 2020
$16.6M
Heartland Institute for Clinical and Translational ResearchUL1TR000001 · NCATS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BAROHN, RICHARD J. · 2012 to 2015
$13.0M
Women's Alzheimer's Risk Reduction in MidlifeP20GM152280 · NIGMS · UNIVERSITY OF KANSAS LAWRENCE · PI Amber Watts · 2024 to 2026
$10.0M
Effect of Aerobic Exercise on Alzheimer's Pathophysiology in Preclinical ADR01AG043962 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI BURNS, JEFFREY MURRAY · 2013 to 2018
$3.0M
Multidisciplinary Research Training Program in Alzheimer's Disease and Related DisordersT32AG078114 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Sandra A Billinger, Eric Dennis Vidoni · 2022 to 2026
$1.2M
Metabolic hormones, aging, and Alzheimer's DiseaseK99AG050490 · NIA · UNIVERSITY OF KANSAS MEDICAL CENTER · PI MORRIS, JILL KATHLEEN · 2016 to 2017
$268k
NCATS NIH HHS UL1 TR000001NIA NIH HHS K99 AG050490NIA NIH HHS P30 AG035982NIA NIH HHS P30 AG072973NIA NIH HHS R01 AG043962NIA NIH HHS T32 AG078114NIGMS NIH HHS P20 GM152280
6 · The paper itself

Abstract

Introduction: Two thirds of Alzheimer's disease (AD) patients are female. Genetic and chronic health risk factors for AD affect females more negatively compared to males. Objective: This multimodal neuroimaging study aimed to examine sex differences in cognitively unimpaired older adults on: (1) amyloid-β via 18F-AV-45 Florbetapir PET imaging, (2) neurodegeneration via T1 weighted MRI volumetrics, (3) cerebral blood flow via ASL-MRI. We identified AD risk factors including genetic ( Methods: Participants were sedentary, amyloid-β positive older adults ( Results: Multivariate analysis of covariance models adjusted for intracranial volume, age, and years of education demonstrated lower volume [ Discussion: Findings suggest genetic and chronic health risk factors are associated with sex-specific AD neuroimaging biomarkers. Underlying sex-specific biological pathways may explain these findings. Our results highlight the importance of considering sex differences in neuroimaging studies and when developing effective interventions for AD prevention and risk reduction.

Indexed as

Alzheimer's diseasebiomarkersneuroimagingrisk factorssex differences

Identifiers

PMID40444147
PMCPMC12119584

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.